142 related articles for article (PubMed ID: 35345221)
21. The effect of topical sirolimus on superficial Kaposiform haemangioendothelioma.
Liu YX; Zhang J; Nie XL; Chen YL; Wang ZY; Xu ZG
Australas J Dermatol; 2021 May; 62(2):e329-e331. PubMed ID: 33216947
[No Abstract] [Full Text] [Related]
22. Spinal Kaposiform Hemangioendotheliomas: Is There a Role for Endovascular Treatment?
Demartini Z; Afornali S; Teixeira BCA; Maeda AK; Carboni EK; Cardoso-Demartini AA
Pediatr Neurosurg; 2022; 57(5):385-388. PubMed ID: 35696991
[No Abstract] [Full Text] [Related]
23. Kaposiform hemangioendothelioma in an unusual site: A report of two cases in children.
Bhattacharya S; Roy P; Chatterjee U; Bhattacharyya A
Indian J Pathol Microbiol; 2022; 65(1):167-169. PubMed ID: 35074987
[TBL] [Abstract][Full Text] [Related]
24. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
[TBL] [Abstract][Full Text] [Related]
25. Image Gallery: Kaposiform haemangioendothelioma.
Moscarella E; Ametrano O; Diplomatico M; De Chiara C; Capasso M; Errico ME; Picciocchi R
Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
[No Abstract] [Full Text] [Related]
26. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.
Reichel A; Hamm H; Wiegering V; Wiewrodt B; Neubauer H; Ernestus K; Winkler B
J Dtsch Dermatol Ges; 2017 Mar; 15(3):329-331. PubMed ID: 28220608
[No Abstract] [Full Text] [Related]
27. Giant retroperitoneal Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: A case report.
Wu D; Xu J; Wang P; Zhou S
Asian J Surg; 2023 Feb; 46(2):1014-1015. PubMed ID: 35961905
[No Abstract] [Full Text] [Related]
28. [Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon].
Inguanzo-Ortiz M; Piqué-Duran E; Aparicio-Sánchez JL; Vaca-Arellano MR
An Pediatr (Engl Ed); 2018 May; 88(5):292-293. PubMed ID: 29625805
[No Abstract] [Full Text] [Related]
29. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
Zhang X; Yang K; Chen S; Ji Y
J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
[TBL] [Abstract][Full Text] [Related]
30. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
31. Bifocal Tibial Kaposiform Hemangioendothelioma Responsive to Vincristine Therapy: A Case Report.
Bsisu IK; Alkharabsheh MM; Al-Zu'bi BB; Almuhaisen G; Awidi AS; Samarah OQ
Am J Case Rep; 2019 Dec; 20():1923-1929. PubMed ID: 31866667
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.
Wang Z; Li K; Dong K; Xiao X; Zheng S
J Pediatr Hematol Oncol; 2015 Jan; 37(1):72-3. PubMed ID: 24309604
[No Abstract] [Full Text] [Related]
33. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
[TBL] [Abstract][Full Text] [Related]
34. Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma.
Tasani M; Ancliff P; Glover M
Br J Dermatol; 2017 Dec; 177(6):e344-e346. PubMed ID: 28485019
[No Abstract] [Full Text] [Related]
35. Kaposiform haemangioendothelioma of the spine associated with fixed hyperlordotic deformity and Kasabach-Merritt Syndrome: a case report and literature review.
Chin LHQ; Fung KKF; Chan JPK; Kan ANC; Yuen MK
Skeletal Radiol; 2023 Apr; 52(4):783-790. PubMed ID: 35948828
[TBL] [Abstract][Full Text] [Related]
36. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
Chan S; Cassarino DS
JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
[No Abstract] [Full Text] [Related]
37. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of Kasabach-Merritt phenomenon in a young adult with a congenital kaposiform hemangioendothelioma.
Ivars M; Triana P; López-Gutiérrez JC
Pediatr Dermatol; 2020 Sep; 37(5):958-959. PubMed ID: 32543761
[TBL] [Abstract][Full Text] [Related]
39. A case of sirolimus treatment of kaposiform hemangioendothelioma in the neck.
Kuwabara Y; Ozeki M; Hira K; Fujisaki H; Ohnishi H
Pediatr Int; 2022 Jan; 64(1):e15000. PubMed ID: 35289458
[No Abstract] [Full Text] [Related]
40. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
Der Sarkissian SA; Wong XL; Kossard S; Hong A; Sebaratnam DF
Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
